After four years of research into Polyendocrine Metabolic Ovarian Syndrome (PMOS) (previously known as polycystic ovary syndrome (PCOS)), the SPIOMET4HEALTH Final Policy Event will bring together researchers, patients, patient organisations and policymakers to share the project’s key findings and discuss what they could mean for the future of policy, clinical practice and care for adolescent girls and young women.
During this meeting, Asphalion experts, as the project’s regulatory partners, will briefly discuss the regulatory pathway the project has followed.
With clinical sites across five European countries, SPIOMET4HEALTH has brought together an international effort to generate evidence with the potential to improve how PMOS is understood, managed and treated across Europe.
Participation is free, both in person and online. It will take place on 6 November 2026 at 10:00 CET in Bologna (Italy).
You can find more information and register here
If you have any questions, you can contact us at [email protected]
